# A Study to Evaluate the PK Similarity of AK104 in Healthy Chinese Male Subjects

> **NCT05559554** · PHASE1 · COMPLETED · sponsor: **Akeso** · enrollment: 100 (actual)

## Conditions studied

- Healthy Male Subjects

## Interventions

- **DRUG:** AK104 (before the change)
- **DRUG:** AK104 (after the change)

## Key facts

- **NCT ID:** NCT05559554
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-25
- **Primary completion:** 2023-03-24
- **Final completion:** 2023-04-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05559554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05559554, "A Study to Evaluate the PK Similarity of AK104 in Healthy Chinese Male Subjects". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05559554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*